Brain and Cognitive Reserve and Neuropsychological Tests

Roe, C.M., Ances, B.M., Head, D., Babulal, G.M., Stout, S.H., Grant, E.A., Xiong, C., Holtzman, D.M., Benzinger, T.L.S., Fagan, A.M., & Morris, J.C. (2018). Incident cognitive impairment: longitudinal changes in molecular, structural and cognitive biomarkers. Brain.

Ingber AP, Hassenstab J, Fagan AM, Benzinger TLS, Grant EA, Holtzman DM, Morris JC, Roe CM. Cerebrospinal fluid biomarkers and reserve variables as predictors of future “non-cognitive” outcomes of Alzheimer disease. Journal of Alzheimer’s Disease 2016;52:1055-1064.

Hassenstab J, Monsell SE, Mock C, Roe CM, Cairns NJ, Morris JC, Kukull W. Neuropsychological markers of cognitive decline in persons with Alzheimer’s disease neuropathology. Journal of Neuropathology and Experimental Neurology 2015:74:1086-1092.

Gordon BA, Wang Q, Najmi S, Hsu P, Roe CM, Morris JC, Benzinger TLS. The effects of white matter damage and amyloid deposition on cognition. NeuroImage: Clinical 2015; 8:246-252. PMCID: PMC4474174.

Shim YS, Yang D-W, Roe CM, Coats MA, Benzinger TL, Xiong C, Galvin JE, Cairns NJ, Morris JC. Pathological correlates of white matter hyperintensities on magnetic resonance imaging.  Dementia and Geriatric Cognitive Disorders 2015;39:92-104. PMCID: PMC4312498.

Pizzie R, Hindman H, Roe CM, Head D, Grant E, Morris JC, Hassenstab JJ. Physical Activity and Cognitive Trajectories in Cognitively Normal Aduts: The Adult Children Study. Alzheimer’s Disease & Associated Disorders 2014; 28:50-57. PMCID: PMC3778080.

Shim YS, Roe CM, Buckles V, Morris JC. Clinicopathologic Study of Alzheimer’s Disease: Alzheimer mimics. Journal of Alzheimer’s Disease 2013; 35:799-811. PMCID: PMC3725959.

Roe CM, Fagan AM, Grant EA, Hassenstab J, Moulder KL, Maue Dreyfus D, Sutphen CL, Benzinger TLS, Mintun MA, Holtzman DM, Morris JC. Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later. Neurology 2013;80:1784–1791. PMCID: PMC3719431.